Floatz logo

qh101

Meningeal Metastasis

Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Meningeal Metastasis cohort.

Asset / SponsorPhaseRating
Biottt001
Henan Cancer Hospital
Phase 1/2CCC
qh101 cell
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Early Phase 1C
qh104 cell
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
N/AD
Lorlatinib
Sichuan Cancer Hospital and Research Institute
D

Same molecule, other indications

qh101 is also rated in:

cancerDormant
CC
Indicative ·
45 / 100
View asset →
metastatic malignant neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
myelodysplastic syndromeDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →